Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic, and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chai

Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic, and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chain Reaction, Next-Generation Sequencing and Others), By End User (Hospitals, Maternity And Specialty Clinics, and Diagnostic Centers), and By Region - Trends, Analysis and Forecast till 2034

The prenatal and neonatal genetic testing market is experiencing significant growth owing to advancements in technology, increasing awareness of genetic diseases, and growth in demand for early diagnosis and its causes. Growing focus on the development of novel testing strategies assists in market proliferation. These include chromosome microarray, polymer chain reaction, and next-generation sequencing that are used in the diagnosis of genetic disorders including but not limited to Down's syndrome, cystic fibrosis, and sickle-cell anemia, among others. The increasing cost of healthcare and growing research activities in the region and across the world are aiding the growth of the market.

Prenatal and Newborn Genetic Testing Market Report Highlights:

• In 2023, the prenatal and newborn genetic testing market size was estimated to be worth USD 5.99 billion.
• By 2034, the target market is expected to grow by USD 19.21 billion at a CAGR of 11.7%.
• North America held the largest share of the market in 2024.
• Asia Pacific is projected to be the fastest-growing market in the coming years.
• By disease, Down's syndrome is expected to account for the largest share of the prenatal and newborn genetic testing market in upcoming years.
• On the basis of product, the diagnostic testing segment is expected to lead the market during the forecast period.
• Based on technology, the market is being dominated by the next-generation sequencing segment.
• The hospital segment holds the largest prenatal and newborn genetic testing market share during the forecast period.

Prenatal and Newborn Genetic Testing Market Key Highlights:

North America: The share can be considered high because there is high adoption of advanced genetic testing technologies, quite supportive reimbursement policies, and well-established healthcare infrastructure in this region. Countries like the U.S. and Canada have taken up the mantle of leading in implementing newborn screening programs and prenatal testing protocols.

Asia Pacific: The market for genetic testing in this region is projected to progress very rapidly due to ever-growing healthcare expenditures, betterment and improvement in its healthcare infrastructure, and rising awareness of the benefits of early diagnosis. Major countries like China, India, and Japan will probably drive considerable adoption of genetic testing technologies.

Prenatal and Postnatal Genetic Testing Toward Personalized Care:

According to a research article published by Elsevier B.V., this article highlights that perinatal care is changing as a result of non-invasive prenatal testing and the use of genomic sequencing in postnatal newborn screening. They increase the precision of prenatal and neonatal screening, enabling tailored treatments and early interventions. Non-invasive perinatal testing includes both non-invasive prenatal testing prior to delivery and neonatal genetic sequencing based on saliva samples postpartum.

Browse ∼46 market data tables and ∼41 figures through ∼179 slides and in-depth TOC on “Prenatal and Newborn Genetic Testing Market Size, Share, By Product (Diagnostic and Screening), By Disease (Down's syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia, and Other Diseases), By Technology (Chromosomal Microarray, Polymerase Chain Reaction, Next-Generation Sequencing, and Others), By End-User (Hospitals, Maternity And Specialty Clinics, and Diagnostic Centers), and By Region - Trends, Analysis, and Forecast till 2034”

Prenatal and Newborn Genetic Testing Market Competitive Landscape:

The key players operating in the prenatal and newborn genetic testing market include Natera, Inc., Illumina, Inc., Roche Holdings AG, Qiagen N.V., LabCorp, Genomics plc, Myriad Genetics, Inc., PerkinElmer, Inc., Invitae Corporation, ArcherDX, Inc., Fulgent Genetics, Inc., Sema4, BGI Group, Counsyl, Genetic Technologies Limited.